期刊
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
卷 35, 期 1, 页码 1345-1358出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2020.1780227
关键词
Paullone; trypanothione synthetase; Leishmania; thiol; inhibition mode
资金
- Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) [POS_NAC_2013_1_114477]
- Comision Sectorial de Investigacion Cientifica (CSIC)
- Universidad de la Republica Uruguay [3404]
- Fondo para la Convergencia Estructural del MERCOSUR (Mercado Comun del Sur)
- Institut Pasteur Paris [ACIP 17-2015]
- European Cooperation in Science and Technology (COST) [CM1307]
- German Bundesministerium fur Bildung und Forschung (KMUinnovativ 5) [0315814]
- Deutsche Forschungsgemeinschaft (DFG) [KU 1371/9-1]
Trypanothione synthetase (TryS) producesN(1),N-8-bis(glutathionyl)spermidine (or trypanothione) at the expense of ATP. Trypanothione is a metabolite unique and essential for survival and drug-resistance of trypanosomatid parasites. In this study, we report the mechanistic and biological characterisation of optimisedN(5)-substituted paullone analogues with anti-TryS activity. Several of the new derivatives retained submicromolar IC(50)against leishmanial TryS. The binding mode to TryS of the most potent paullones has been revealed by means of kinetic, biophysical and molecular modelling approaches. A subset of analogues showed an improved potency (EC(50)0.5-10 mu M) and selectivity (20-35) against the clinically relevant stage ofLeishmania braziliensis(mucocutaneous leishmaniasis) andL. infantum(visceral leishmaniasis). For a selected derivative, the mode of action involved intracellular depletion of trypanothione. Our findings shed light on the molecular interaction of TryS with rationally designed inhibitors and disclose a new set of compounds with on-target activity against differentLeishmaniaspecies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据